NASDAQ · NNOX
Healthcare · Medical - Devices
$0.75
Up+$0.07 (+9.71%)
Updated Sep 17, 2026, 3:37 AM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
NNOX closed at $0.75 after 20 trading sessions, down 18.96% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $0.6855 | $0.76 | $0.675 | $0.7537 | 1.41M |
| Sep 15, 2026 | $0.7164 | $0.73 | $0.675 | $0.687 | 1.09M |
| Sep 14, 2026 | $0.7361 | $0.767 | $0.6998 | $0.70 | 1.09M |
| Sep 11, 2026 | $0.745 | $0.75 | $0.7134 | $0.7238 | 847.21K |
| Sep 10, 2026 | $0.78 | $0.78 | $0.725 | $0.7301 | 1.22M |
| Sep 9, 2026 | $0.7598 | $0.7979 | $0.6735 | $0.78 | 4.85M |
| Sep 8, 2026 | $0.8449 | $0.9581 | $0.812 | $0.9303 | 2.64M |
| Sep 4, 2026 | $0.7201 | $0.8687 | $0.7201 | $0.8298 | 6.23M |
| Sep 3, 2026 | $0.7669 | $0.79 | $0.7102 | $0.7127 | 1.41M |
| Sep 2, 2026 | $0.7974 | $0.80 | $0.7605 | $0.7638 | 554.76K |
| Sep 1, 2026 | $0.80 | $0.8099 | $0.775 | $0.7859 | 745.53K |
| Aug 31, 2026 | $0.815 | $0.8267 | $0.775 | $0.8074 | 1.44M |
| Aug 28, 2026 | $0.8734 | $0.88 | $0.801 | $0.8296 | 903.32K |
| Aug 27, 2026 | $0.885 | $0.89 | $0.8412 | $0.8424 | 699.85K |
| Aug 26, 2026 | $0.8761 | $0.905 | $0.85 | $0.8758 | 499.15K |
| Aug 25, 2026 | $0.89 | $0.91 | $0.842 | $0.863 | 812.42K |
| Aug 24, 2026 | $0.8872 | $0.8916 | $0.8334 | $0.8642 | 797.64K |
| Aug 21, 2026 | $0.90 | $0.9257 | $0.8524 | $0.8599 | 781.52K |
| Aug 20, 2026 | $0.94 | $0.9485 | $0.8832 | $0.885 | 652.58K |
| Aug 19, 2026 | $0.89 | $0.94 | $0.89 | $0.93 | 923.5K |
The latest Smart Investors Daily articles mentioning NNOX.
NNOX research
Company profile and research snapshot.
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 17, 2026 | Cantor Fitzgerald | Overweight | — |
| Jul 7, 2026 | Alliance Global Partners | Neutral | — |
| Apr 20, 2026 | D. Boral Capital | Buy | — |
| Apr 13, 2026 | D. Boral Capital | Buy | — |
| Mar 3, 2026 | D. Boral Capital | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 9, 2026
Nano X Imaging Ltd (NNOX) reports strong top-line growth driven by teleradiology services, while navigating a $40.7 million impairment and cash conservation efforts.
Yahoo · Sep 9, 2026
Nanox (NASDAQ:NNOX) reported a 37% increase in second-quarter 2026 revenue to $4. 2 million, but its GAAP net loss widened to $55.
Yahoo · Sep 9, 2026
Nano-X Imaging (NASDAQ:NNOX) reported second-quarter 2026 revenue growth driven by its teleradiology, health IT and AI businesses, while recording a substantial non-cash impairment charge and outlining cost-reduction actions intended to extend its cash runway. Revenue for the quarter ended June 30
ChartMill · Sep 9, 2026
Nano-X Imaging shares drop after Q2 revenue and profit miss estimates, hit by impairment charge and lower cash balance.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning NNOX.
